Treating type 2 diabetes patients with a cholesterol-lowering drug called fenofibrate cuts the risk of a first diabetes-related limb amputation by 36%, according to a new study.
Fenofibrate Cuts Amputation Risk in DiabetesCourtesy WebMD Health Thu, 05/21/2009 - 17:48
Treating type 2 diabetes patients with a cholesterol-lowering drug called fenofibrate cuts the risk of a first diabetes-related limb amputation by 36%, according to a new study. Popular products More related itemsStudy: Diet Can Help Avoid Diabetes Drugs
ASMBS: Obesity Surgery Resolves Diabetes but for How...
Very Low Blood Sugar Linked to Dementia
Pedifix Wart Stick Solid-stick Wart Remover Net...
Ride 'Em Cowgirl! Sex Position Secrets For Better...
|
Popular by tags WeekMonth |
Post new comment